Neoleukin Therapeutics In... (NLTX)
NASDAQ: NLTX
· Real-Time Price · USD
3.49
0.05 (1.45%)
At close: Dec 18, 2023, 10:00 PM
Neoleukin Therapeutics Revenue Breakdown
| Period Ending | Dec 31, 2024 |
|---|---|
| Reportable Segment Revenue | 925K |
| Reportable Segment Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 8.16M | 10.14M | 5.89M | 5.32M | 4.95M | 3.49M | 4.03M | 4.25M | 4.14M | 4.92M | 4.66M | 5.41M | 5.56M | 5.3M | 5.24M | 4.85M | 3.86M | 4.93M | 3.57M | 3.47M | 10.38M | 2.42M | 2.56M | 2.73M | 4.48M | 4.31M | 4.31M | 4.97M | 3.61M | 3.52M | 2.75M | 3.33M | 2.15M | 1.83M | 1.95M | 1.67M | 1.23M | 1.17M | 1.47M |
| Selling, General, and Administrative Revenue Growth | -19.55% | +72.04% | +10.91% | +7.33% | +41.81% | -13.29% | -5.25% | +2.71% | -15.81% | +5.38% | -13.85% | -2.56% | +4.83% | +1.13% | +8.04% | +25.67% | -21.64% | +37.87% | +3.03% | -66.59% | +328.39% | -5.17% | -6.34% | -39.16% | +3.94% | +0.12% | -13.35% | +37.60% | +2.67% | +28.23% | -17.59% | +55.00% | +17.43% | -6.30% | +17.16% | +35.53% | +4.86% | -20.31% | n/a |
| Research and Development Revenue | 17.76M | 53.04M | 16.29M | 15.74M | 617K | -426K | 7.69M | 10M | 9.47M | 10.96M | 10.7M | 9.76M | 9.9M | 9.82M | 9.71M | 7.79M | 6.22M | 4.84M | 5.5M | 4.89M | 1.42M | -2M | 104K | 2.57M | 10.71M | 18M | 10.51M | 11.56M | 8.46M | 10.47M | 5.78M | 8.13M | 6.13M | 9.23M | 4.88M | 3.93M | 3.69M | 3.62M | 4.57M |
| Research and Development Revenue Growth | -66.51% | +225.67% | +3.44% | +2451.70% | -244.84% | -105.54% | -23.11% | +5.60% | -13.55% | +2.38% | +9.64% | -1.37% | +0.73% | +1.21% | +24.66% | +25.27% | +28.35% | -11.91% | +12.48% | +244.23% | -171.18% | -2018.27% | -95.96% | -75.99% | -40.47% | +71.26% | -9.09% | +36.70% | -19.27% | +81.32% | -28.96% | +32.57% | -33.58% | +89.20% | +24.33% | +6.48% | +1.88% | -20.76% | n/a |